Get research updatesPublic study records, presented in a clearer and more patient-friendly format for mental health research discovery.
Recruitment is currently suspended.
Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.
In BulgariaThis study has finished and is no longer accepting participants.
Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.
In GermanyThis study has finished and is no longer accepting participants.
Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.
In RomaniaThis study has finished and is no longer accepting participants.
Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.
In LithuaniaThis study has finished and is no longer accepting participants.
Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.
In FranceA Phase 3 Study of SME3110 (Fluvoxamine Maleate) in Pediatric/Adolescent Subjects With Obsessive Compulsive Disorder
This study has finished and is no longer accepting participants.
Location not clearly listedA Phase 3 Study to Assess the Long Term Safety, Tolerability, and Durability of Treatment Effect of ALKS 3831 in Subjects with Schizophrenia, Schizophreniform Disorder, or Bipolar I Disorder
Original registry wording; source language not specified.
This study has finished and is no longer accepting participants.
Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.
In AustriaThis study has finished and is no longer accepting participants.
Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.
In BulgariaResearchers are comparing TNX-102 SL and placebo to find out how the approaches affect post-traumatic stress symptoms in people with PTSD.
This study ended early.
Multiple locations, including PhoenixResearchers are comparing DT120 and placebo to find out how the approaches affect anxiety symptoms in adults with an anxiety condition.
This study is no longer accepting new participants.
Multiple locations, including GilbertResearchers are comparing DT120 and placebo to find out how the approaches affect depression symptoms in adults with depression.
This study is no longer accepting new participants.
Multiple locations, including Little RockResearchers are comparing DT120, placebo and a simulated comparison procedure to find out how the approaches affect anxiety symptoms in adults with an anxiety condition.
This study is no longer accepting new participants.
Multiple locations, including Little RockWe gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.